All In MedTech

FDA Clearance Tracker · P040002-S039

POWERLINK SYSTEM WITH INTUITRAK DELIVERY SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 16, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 16, 2013

Approved

Time to decision

285 days

Received Jul 5, 2012. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P040002-S039
Device name
POWERLINK SYSTEM WITH INTUITRAK DELIVERY SYSTEM
Applicant location
Irvine, CA
Received
Jul 5, 2012
Decided
Apr 16, 2013
Decision
Approved
Supplement type
Normal 180 Day Track
Original approval
P040002

Device type

Device class
Class III

Every decision under product code MIH

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE ADDITION OF BILATERAL PERCUTANEOUS ACCESS TO THE DEVICE LABELING.

Source documents

Other decisions for Endologix, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.